Different mechanisms for resistance to trastuzumab versus lapatinib in HER2-positive breast cancers--role of estrogen receptor and HER2 reactivation (Q35889621)

From Wikidata
Jump to navigation Jump to search
scientific article published on 28 November 2011
edit
Language Label Description Also known as
English
Different mechanisms for resistance to trastuzumab versus lapatinib in HER2-positive breast cancers--role of estrogen receptor and HER2 reactivation
scientific article published on 28 November 2011

    Statements

    Different mechanisms for resistance to trastuzumab versus lapatinib in HER2-positive breast cancers--role of estrogen receptor and HER2 reactivation (English)
    Yen-Chao Wang
    Gladys Morrison
    Ryan Gillihan
    Jun Guo
    Robin M Ward
    Xiaoyong Fu
    Maria F Botero
    Nuala A Healy
    Susan G Hilsenbeck
    Gail Lewis Phillips
    Gary C Chamness
    Mothaffar F Rimawi
    C Kent Osborne
    28 November 2011
    R121

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit